52
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Bioresponsive cancer-targeted polysaccharide nanosystem to inhibit angiogenesis

, , &
Pages 7419-7431 | Published online: 10 Oct 2017

References

  • SiegelRLMillerKDJemalACancer statistics, 2017CA: A Cancer Journal for Clinicians201767173028055103
  • DeVitaVTChuEA history of cancer chemotherapyCancer Res200868218643865318974103
  • SahaBHaldarUDePPolymer-chlorambucil drug conjugates: a dynamic platform of anticancer drug deliveryMacromol Rapid Commun201637131015102027159378
  • JohnsonRPJeongYIJohnJVLipo-poly(L-histidine) hybrid materials with pH-sensitivity, intracellular delivery efficiency, and intrinsic targetability to cancer cellsMacromol Rapid Commun201435988889424596253
  • SousaEHSRidnourLAGouveiaFSThiol-activated HNO release from a ruthenium antiangiogenesis complex and HIF-1α inhibition for cancer therapyACS Chem Biol20161172057206527191177
  • ChenYGaoFShaXFangXDual-functional C(RGDYK)-decorated pluronic micelles for antiangiogenesis and drug resistant tumor treatment in vitroNanomed Nanotechnol2016122501
  • FolkmanJAntiangiogenesis in cancer therapy – endostatin and its mechanisms of actionExp Cell Res2006312559460716376330
  • SamantRSShevdeLARecent advances in anti-angiogenic therapy of cancerOncotarget20112312213421399234
  • IvanovaVRousevaRKolarovaMSerkedjievaJRachevRManolovaNIsolation of a polysaccharide with antiviral effect from Ulva lactucaPrep Biochem199424283978072958
  • NieSXingYKimGJSimonsJWNanotechnology applications in cancerAnnu Rev Biomed Eng2007925728817439359
  • SathivelARaghavendranHRSrinivasanPDevakiTAnti-peroxidative and anti-hyperlipidemic nature of Ulva lactuca crude polysaccharide on D-galactosamine induced hepatitis in ratsFood Chem Toxicol200846103262326718706469
  • NaitoHWakabayashiTKidoyaHEndothelial side population cells contribute to tumor angiogenesis and antiangiogenic drug resistanceCancer Res201676113200321027197162
  • JaysonGCKerbelREllisLMHarrisALAntiangiogenic therapy in oncology: current status and future directionsLancet20163881004351852926853587
  • SiemannDWChaplinDJHorsmanMRVascular-targeting therapies for treatment of malignant diseaseCancer2004100122491249915197790
  • KerbelRSKamenBAThe anti-angiogenic basis of metronomic chemotherapyNat Rev Cancer20044642343615170445
  • MaedaYPittellaFNomotoTFine-tuning of charge-conversion polymer structure for efficient endosomal escape of siRNA-loaded calcium phosphate hybrid micellesMacromol Rapid Commun201435131211121524715658
  • HuHYouYHeLThe rational design of NAMI-A-loaded mesoporous silica nanoparticles as antiangiogenic nanosystemsJ Mater Chem B201533063386346
  • JiangWFuYYangFGracilaria lemaneiformis polysaccharide as integrin-targeting surface decorator of selenium nanoparticles to achieve enhanced anticancer efficacyACS Appl Mater Interfaces2014616137381374825073123
  • PeerDKarpJMHongSFarokhzadOCMargalitRLangerRNanocarriers as an emerging platform for cancer therapyNat Nanotechnol200721275176018654426
  • FuXYYangYHLiXLRGD peptide-conjugated selenium nanoparticles: antiangiogenesis by suppressing VEGF-VEGFR2-ERK/AKT pathwayNanomedicine20161261627163926961468
  • ChenTLiuYZhengWJLiuJWongYSRuthenium polypyridyl complexes that induce mitochondria-mediated apoptosis in cancer cellsInorg Chem201049146366636820527894
  • SunDDLiuYNYuQQThe effects of luminescent ruthenium(II) polypyridyl functionalized selenium nanoparticles on bFGF-induced angiogenesis and AKT/ERK signalingBiomaterials201334117118023059005
  • FangXYJiangWTHuangYYSize changeable nanosystems for precise drug controlled release and efficient overcoming of cancer multidrug resistanceJ Mater Chem B201755944952
  • KuhnWHargitayBKatchalskyAEisenbergHReversible dilation and contraction by changing the state of Ionization of high-polymer acid networksNature19501654196514516